PF-04958242

• CAT Number: I008670
• CAS Number: 1258963-59-5
• Molecular Formula: C18H20N2O4S2
• Molecular Weight: 392.49
• Purity: ≥95%
• Synonyms: PF-04958242; PF 04958242; PF04958242.;2-Propanesulfonamide, N-((3S,4S)-4-(4-(5-cyano-2-thienyl)phenoxy)tetrahydro-3-furanyl)-
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO
• Storage: 0 - 4 °C for short term, or -20 °C for long term
• IUPAC Name: N-[(3S,4S)-4-[4-(5-cyanothiophen-2-yl)phenoxy]oxolan-3-yl]propane-2-sulfonamide
• InChI: InChI=1S/C18H20N2O4S2/c1-12(2)26(21,22)20-16-10-23-11-17(16)24-14-5-3-13(4-6-14)18-8-7-15(9-19)25-18/h3-8,12,16-17,20H,10-11H2,1-2H3/t16-,17+/m0/s1
• InChIKey: TTYKUKSFWHEBLI-DLBZAZTESA-N
• SMILES: CC(C)S(=O)(=O)NC1COCC1OC2=CC=C(C=C2)C3=CC=C(S3)C#N

PF-04958242(CAT: I008670) is an investigational small-molecule compound that functions as a selective antagonist of the muscarinic acetylcholine receptor subtype M4 (M4R). It is primarily studied for its potential in treating neuropsychiatric disorders such as schizophrenia. By selectively blocking M4 receptors, PF-04958242 is thought to modulate cholinergic signaling, which may help alleviate symptoms of cognitive and behavioral dysfunction associated with conditions like schizophrenia. Its selectivity for M4 receptors minimizes the side effects typically associated with non-specific muscarinic antagonists, making it a promising candidate for further development in the field of psychiatric and neurological disorders.